Trial intelligence / Profile preview

Caffeine loading dose effect on diaphragmatic electrical activity in premature newborns

RBR-4x9j9hqCompleted

Sponsor
Hospital Israelita Albert Einstein
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of caffeine in apnea of prematurity (AOP), sponsored by Hospital Israelita Albert Einstein. Primary endpoint: Change in diaphragmatic electrical activity. Started Jul 2018; status: completed.

02

Drugs

caffeine
03

Conditions

apnea of prematurity (AOP)

Beyond the preview

Go deeper on RBR-4x9j9hq.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-4x9j9hq.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call